Objective: To observe the effect and mechanism of Garlicin in treating coronary heart disease (CHD) with angina pectoris. Methods: Clinical study: 55 patients were selected and randomized into the Garlicin group and the nitroglycerin group. To Garlicin group, 60 mg of Garlicin was given by adding in 5% glucose solution for intravenous dripping once per day, the therapeutic
展开▼
机译：materialmodell没有。 72 foer Betong：Erfarenheter fran en Experimentell och Numberisk studie（material modell no.72 for concrete-Experience from a Experimental and Numerical study）。
